FDA
-
-
-
-
-
-
-
Vivos Therapeutics raises $4.64 million through warrant exercise
-
-
-
-
-
-
-
Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device
-
-
-
-
-
-
-
Vivos Therapeutics Adds to Management Team to Support Expansion and Growth
-
-
-
-
-
-
-
Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update
-
-
-
-
-
-
-
Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
-
-
-
-
-
-
-
Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance
-
-
-
-
-
-
-
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth Opportunities
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

